Insulet Corporation

NasdaqGS:PODD 주식 보고서

시가총액: US$14.0b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Insulet 관리

관리 기준 확인 4/4

Insulet's CEO는 Jim Hollingshead, Jun2022 에 임명되었습니다 의 임기는 4.92 년입니다. 총 연간 보상은 $ 12.38M, 6.8% 로 구성됩니다. 6.8% 급여 및 93.2% 보너스(회사 주식 및 옵션 포함). 는 $ 3.43M 가치에 해당하는 회사 주식의 0.025% 직접 소유합니다. 3.43M. 경영진과 이사회의 평균 재임 기간은 각각 2 년과 3.6 년입니다.

주요 정보

Jim Hollingshead

최고 경영자

US$12.4m

총 보상

CEO 급여 비율6.8%
CEO 임기2yrs
CEO 소유권0.02%
경영진 평균 재임 기간2yrs
이사회 평균 재임 기간3.6yrs

최근 관리 업데이트

Recent updates

Insulet Corporation: Insulin Pump Provider Fighting Back After Torrid 2023

Jun 11

We Like These Underlying Return On Capital Trends At Insulet (NASDAQ:PODD)

May 26
We Like These Underlying Return On Capital Trends At Insulet (NASDAQ:PODD)

At US$166, Is It Time To Put Insulet Corporation (NASDAQ:PODD) On Your Watch List?

May 12
At US$166, Is It Time To Put Insulet Corporation (NASDAQ:PODD) On Your Watch List?

Is Insulet (NASDAQ:PODD) A Risky Investment?

Apr 29
Is Insulet (NASDAQ:PODD) A Risky Investment?

Insulet Corporation's (NASDAQ:PODD) Earnings Haven't Escaped The Attention Of Investors

Apr 14
Insulet Corporation's (NASDAQ:PODD) Earnings Haven't Escaped The Attention Of Investors

Estimating The Fair Value Of Insulet Corporation (NASDAQ:PODD)

Mar 31
Estimating The Fair Value Of Insulet Corporation (NASDAQ:PODD)

Insulet: Insulating Patients, Investors Still Have To Wait

Mar 28

Insulet (NASDAQ:PODD) Is Doing The Right Things To Multiply Its Share Price

Feb 19
Insulet (NASDAQ:PODD) Is Doing The Right Things To Multiply Its Share Price

Is Insulet Corporation (NASDAQ:PODD) Potentially Undervalued?

Jan 22
Is Insulet Corporation (NASDAQ:PODD) Potentially Undervalued?

Insulet: An Interesting, Yet Expensive, Story

Jan 10

Is Insulet (NASDAQ:PODD) Using Too Much Debt?

Jan 09
Is Insulet (NASDAQ:PODD) Using Too Much Debt?

Insulet Corporation's (NASDAQ:PODD) Earnings Haven't Escaped The Attention Of Investors

Dec 27
Insulet Corporation's (NASDAQ:PODD) Earnings Haven't Escaped The Attention Of Investors

Estimating The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)

Nov 14
Estimating The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)

Insulet (NASDAQ:PODD) Shareholders Will Want The ROCE Trajectory To Continue

Oct 31
Insulet (NASDAQ:PODD) Shareholders Will Want The ROCE Trajectory To Continue

We Think Insulet (NASDAQ:PODD) Is Taking Some Risk With Its Debt

Oct 01
We Think Insulet (NASDAQ:PODD) Is Taking Some Risk With Its Debt

Is There Now An Opportunity In Insulet Corporation (NASDAQ:PODD)?

Sep 16
Is There Now An Opportunity In Insulet Corporation (NASDAQ:PODD)?

Estimating The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)

Aug 14
Estimating The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)

Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger

Jul 31
Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger

Is Insulet (NASDAQ:PODD) Using Too Much Debt?

Jun 18
Is Insulet (NASDAQ:PODD) Using Too Much Debt?

Getting In Cheap On Insulet Corporation (NASDAQ:PODD) Might Be Difficult

May 22
Getting In Cheap On Insulet Corporation (NASDAQ:PODD) Might Be Difficult

Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger

Apr 30
Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger

Here's Why Insulet (NASDAQ:PODD) Has A Meaningful Debt Burden

Jan 24
Here's Why Insulet (NASDAQ:PODD) Has A Meaningful Debt Burden

Insulet (NASDAQ:PODD) Shareholders Will Want The ROCE Trajectory To Continue

Dec 28
Insulet (NASDAQ:PODD) Shareholders Will Want The ROCE Trajectory To Continue

Insulet: An Overpriced Play In The Medical Space

Oct 18

Insulet (NASDAQ:PODD) Has A Pretty Healthy Balance Sheet

Oct 02
Insulet (NASDAQ:PODD) Has A Pretty Healthy Balance Sheet

Insulet automated insulin delivery system Omnipod 5 gets CE mark

Sep 20

The Return Trends At Insulet (NASDAQ:PODD) Look Promising

Sep 05
The Return Trends At Insulet (NASDAQ:PODD) Look Promising

Insulet wins FDA nod to use insulin delivery system in 2 – 5-year-olds

Aug 22

CEO 보상 분석

Jim Hollingshead 의 보수는 Insulet 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024n/an/a

US$234m

Dec 31 2023US$12mUS$842k

US$206m

Sep 30 2023n/an/a

US$120m

Jun 30 2023n/an/a

US$63m

Mar 31 2023n/an/a

US$600k

Dec 31 2022US$11mUS$440k

US$5m

Sep 30 2022n/an/a

US$17m

Jun 30 2022n/an/a

US$35m

Mar 31 2022n/an/a

US$45m

Dec 31 2021US$290kn/a

US$17m

Sep 30 2021n/an/a

-US$29m

Jun 30 2021n/an/a

-US$30m

Mar 31 2021n/an/a

US$9m

Dec 31 2020US$259kn/a

US$7m

Sep 30 2020n/an/a

US$29m

Jun 30 2020n/an/a

US$18m

Mar 31 2020n/an/a

US$5m

Dec 31 2019US$261kn/a

US$12m

보상 대 시장: Jim 의 총 보상 ($USD 12.38M )은 US 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 13.50M ).

보상과 수익: Jim 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.


CEO

Jim Hollingshead (61 yo)

2yrs

테뉴어

US$12,379,765

보상

Dr. James R. Hollingshead, also known as Jim, Ph.D. had been President of Sleep & Respiratory Care Business at ResMed Inc. since July 2020 until May 05, 2022 and served as its President of Sleep Business s...


리더십 팀

이름위치테뉴어보상소유권
James Hollingshead
President2yrsUS$12.38m0.025%
$ 3.5m
Lauren Budden
Group VP5.2yrsUS$1.44m0.0081%
$ 1.1m
Mark Field
Senior VP & CTOless than a yearUS$2.37m0.018%
$ 2.6m
John Kapples
Senior VP & General Counsel5.3yrsUS$2.47m0.021%
$ 3.0m
Eric Benjamin
Executive VP6.3yrsUS$3.14m0.024%
$ 3.4m
Ana Chadwick
Executive VPless than a year데이터 없음데이터 없음
Prem Singh
Senior Vice President of Global Operations1.4yrs데이터 없음0.0077%
$ 1.1m
Deborah Gordon
Vice President of Investor Relations9.4yrs데이터 없음데이터 없음
Laetitia Cousin
Senior VP of Regulatory Affairs1.5yrs데이터 없음0.0044%
$ 619.8k
Angela Wiczek
Senior Director of Corporate Communicationsno data데이터 없음데이터 없음
Philip Hildale
Senior Vice President of Sales & Customer Care9.4yrs데이터 없음데이터 없음
Andrew Isaacson
Senior VP of Strategy & Corporate Developmentless than a year데이터 없음데이터 없음

2.0yrs

평균 재임 기간

52yo

평균 연령

경험이 풍부한 관리: PODD 의 관리팀은 경험 ( 2 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
James Hollingshead
President4.9yrsUS$12.38m0.025%
$ 3.5m
Elizabeth Weatherman
Independent Director2.3yrsUS$322.50k0.0040%
$ 552.8k
Timothy Scannell
Independent Chairman9.8yrsUS$387.10k0.049%
$ 6.8m
Robert Sherwin
Chairman of Scientific Advisory Boardno data데이터 없음데이터 없음
Howard Wolpert
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Margaret Lawlor
Member of Educator Advisory Boardno data데이터 없음데이터 없음
Camille Izlar
Member of Educator Advisory Boardno data데이터 없음데이터 없음
Mary Halvorson
Member of Educator Advisory Boardno data데이터 없음데이터 없음
Steven Edelman
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Anne Daly
Member of Educator Advisory Boardno data데이터 없음데이터 없음
John Buse
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Timothy Stonesifer
Independent Directorless than a year데이터 없음데이터 없음

3.6yrs

평균 재임 기간

61yo

평균 연령

경험이 풍부한 이사회: PODD 의 이사회경험(평균 재직 기간 3.6 년)으로 간주됩니다.